Back to search
Drug/Agent Toxicity by Tissue/Organ
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Drug/Agent Toxicity by Tissue/Organ trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Drug/Agent Toxicity by Tissue/Organ trials you may qualify forThe purpose of this observational study is to assess the role of plasma concentration monitoring of treatment drugs for patients with metastatic renal cell carc…
A five-year prospective observational cohort study. The study is focused on observing the relation between static germline variants and therapeutic response in…
Proof of concept: Pilot Study A Pilot, proof of concept, observational study with a long-term goal to develop a minimally invasive wearable Remote Medication M…
Atrial fibrillation is a common complication of both cancer and anticancer drugs but the consequences of such events remain poorly known and are not adressed in…
This study will provide a basis for research on the impact of liver injury caused by antiretroviral therapy in HIV-infected patients. Elevated liver enzymes cal…
This research study is being done to learn more about the short term and long term side effects of treatment with asparaginase drugs, which are commonly used in…
RATIONALE: Drugs used in chemotherapy, such as irinotecan and temozolomide, work in different ways to stop tumor cells from dividing so they stop growing or die…